Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00046839

Public ClinicalTrials.gov record NCT00046839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 8:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Trial of a COX-2 Inhibitor, Celebrex (Celecoxib), [National Screening Committee# 719627] With Limited Field Radiation for Intermediate Prognosis Patients With Locally Advanced Non-Small Cell Lung Cancer, With Analysis of Prognostic Factors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Celecoxib may stop the growth of tumor cells by stopping blood flow to the tumor and may make the tumor cells more sensitive to radiation therapy. PURPOSE: Phase I/II trial to study the effectiveness of combining celecoxib with radiation therapy in treating patients who have locally advanced non-small cell lung cancer.

Study identification

NCT ID
NCT00046839
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
21 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2002
Primary completion
Aug 31, 2011
Completion
Not listed
Last update posted
Nov 16, 2015

Started 2002

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Memorial Hospital Cancer Center Colorado Springs Colorado 80909
University of Florida Shands Cancer Center Gainesville Florida 32610
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136
Regional Radiation Oncology Center at Rome Rome Georgia 30165
Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois 60426
Indiana University Cancer Center Indianapolis Indiana 46202
Wendt Regional Cancer Center at Finley Hospital Dubuque Iowa 52001
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536
West Michigan Cancer Center Kalamazoo Michigan 49007
Virginia Piper Cancer Institute at Abbott-Northwestern Hospital Minneapolis Minnesota 55403
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Park Nicollet Clinic Saint Louis Park Minnesota 55416
CCOP - Kansas City Kansas City Missouri 64131
St. John's Regional Health Center Springfield Missouri 65804
Monmouth Medical Center Long Branch New Jersey 07740
Fox Chase Virtua Health Cancer Program - Marlton Mount Holly New Jersey 08060
Albuquerque Regional Medical Center at Lovelace Sandia Health System Albuquerque New Mexico 87102
University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico 87106
Trinity Cancer Care Center Minot North Dakota 58701
Akron City Hospital at Summa Health System Akron Ohio 44304
Radiation Oncology Center Alliance Ohio 44601
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford Salem Ohio 44460
Cancer Treatment Center Wooster Ohio 44691
Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma 74136
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010
Cancer Center at Paoli Memorial Hospital Paoli Pennsylvania 19301
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497
Mercy Hospital Cancer Center - Scranton Scranton Pennsylvania 18501
CCOP - MainLine Health Wynnewood Pennsylvania 19096
Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania 19096
CCOP - Greenville Greenville South Carolina 29615
CCOP - Upstate Carolina Spartanburg South Carolina 29304
Utah Valley Regional Medical Center - Provo Provo Utah 84603
LDS Hospital Salt Lake City Utah 84143
Dixie Regional Medical Center St. George Utah 84770
St. Joseph Hospital Community Cancer Center Bellingham Washington 98225
North Star Lodge Cancer Center Yakima Washington 98902
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601
Community Memorial Hospital Menomonee Falls Wisconsin 53051
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226
Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin 53295
All Saints Cancer Center at All Saints Healthcare Racine Wisconsin 53405
University of Wisconsin Cancer Center at Aspirus Wausau Hospital Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2015 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00046839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →